Regulation of autoantibody activity by the IL-23-T H 17 axis determines the onset of autoimmune disease

Nature Immunology

Volumn 18, Issue 1, 2017, Pages 104-113

  Pfeifle, René ^a,b   Rothe, Tobias ^a,b   Ipseiz, Natacha ^a,b   Scherer, Hans U ^c   Culemann, Stephan ^a,b   Harre, Ulrike ^a   Ackermann, Jochen A ^a,b   Seefried, Martina ^b,d   Kleyer, Arnd ^a   Uderhardt, Stefan ^a,b   Haugg, Benjamin ^a,b   Hueber, Axel J ^a   Daum, Patrick ^a,b   Heidkamp, Gordon F ^a   Ge, Changrong ^e   Böhm, Sybille ^d   Lux, Anja ^d   Schuh, Wolfgang ^a,b   Magorivska, Iryna ^a   Nandakumar, Kutty S ^e   Lönnblom, Erik ^e   Becker, Christoph ^a   Dudziak, Diana ^a   Wuhrer, Manfred ^c   Rombouts, Yoann ^c,f   Koeleman, Carolien A ^c   Toes, René ^c   Winkler, Thomas H ^b,d   Holmdahl, Rikard ^e   Herrmann, Martin ^a   Blüml, Stephan ^g   Nimmerjahn, Falk ^d   Schett, Georg ^a   Krönke, Gerhard ^a,b   more..

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITÉ DE TOULOUSE   (France)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; AUTOANTIBODY; BETA GALACTOSIDE; BETA GALACTOSIDE ALPHA 2,6 SIALYLTRANSFERASE 1; CXCL1 CHEMOKINE; IMMUNOGLOBULIN G; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 23P19; INTERLEUKIN 6; MESSENGER RNA; SIALYLTRANSFERASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; BETA-D-GALACTOSIDE ALPHA 2-6-SIALYLTRANSFERASE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW DERIVED DENDRITIC CELL; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; FLOW CYTOMETRY; GENOTYPE; GERMINAL CENTER; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGLOBULIN PRODUCING CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PLASMA CELL; PLASMABLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SAMBUCUS NIGRA; SIALYLATION; SPLENIC B CELL; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; DISEASE MODEL; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GLYCOSYLATION; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; INTERLEUKIN-23; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; SIALYLTRANSFERASES; SIGNAL TRANSDUCTION; TH17 CELLS;

EID: 84994632778     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3579     Document Type: Article

References (41)

1. McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205-2219 (2011).
2. Ji, H. et al. Arthritis critically dependent on innate immune system players. Immunity 16, 157-168 (2002).
3. Grant, E. P. et al. Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J. Exp. Med. 196, 1461-1471 (2002).
4. Kleinau, S., Martinsson, P. & Heyman, B. Induction and suppression of collagen-induced arthritis is dependent on distinct Fc? receptors. J. Exp. Med. 191, 1611-1616 (2000).
5. Svensson, L., Jirholt, J., Holmdahl, R. & Jansson, L. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin. Exp. Immunol. 111, 521-526 (1998).
6. Matsumoto, I., Staub, A., Benoist, C. & Mathis, D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286, 1732-1735 (1999).
7. Holmdahl, R., Rubin, K., Klareskog, L., Larsson, E. & Wigzell, H. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum. 29, 400-410 (1986).
8. van Venrooij, W. J., van Beers, J. J. & Pruijn, G. J. Anti-CCP antibodies: the past, the present and the future. Nat. Rev. Rheumatol. 7, 391-398 (2011).
9. Renato, G. M. B cell depletion in early rheumatoid arthritis: a new concept in therapeutics. Ann. NY Acad. Sci. 1173, 729-735 (2009).
10. Rantapää-Dahlqvist, S. et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 48, 2741-2749 (2003).
11. Berglin, E. et al. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res. Ther. 6, R303-R308 (2004).
12. Shiozawa, K. et al. Anticitrullinated protein antibody, but not its titer, is a predictor of radiographic progression and disease activity in rheumatoid arthritis. J. Rheumatol. 39, 694-700 (2012).
13. Ursum, J., Bos, W. H., van Dillen, N., Dijkmans, B. A. & van Schaardenburg, D. Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study. Arthritis Res. Ther. 12, R8 (2010).
14. Lubberts, E. The IL-23-IL-17 axis in inflammatory arthritis. Nat. Rev. Rheumatol. 11, 425-429 (2015).
15. Leipe, J. et al. Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum. 62, 2876-2885 (2010).
16. Murphy, C. A. et al. Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198, 1951-1957 (2003).
17. Yamada, H. et al. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann. Rheum. Dis. 67, 1299-1304 (2008).
18. Pöllinger, B. IL-17 producing T cells in mouse models of multiple sclerosis and rheumatoid arthritis. J. Mol. Med. 90, 613-624 (2012).
19. Corrigall, V. M. & Panayi, G. S. Autoantigens and immune pathways in rheumatoid arthritis. Crit. Rev. Immunol. 22, 281-293 (2002).
20. Nimmerjahn, F. & Ravetch, J. V. Antibody-mediated modulation of immune responses. Immunol. Rev. 236, 265-275 (2010).
21. Anthony, R. M. et al. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320, 373-376 (2008).
22. Cornelissen, F. et al. IL-23 dependent and independent stages of experimental arthritis: no clinical effect of therapeutic IL-23p19 inhibition in collagen-induced arthritis. PLoS One 8, e57553 (2013).
23. Mitsdoerffer, M. et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc. Natl. Acad. Sci. USA 107, 14292-14297 (2010).
24. Hirota, K. et al. Plasticity of TH17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses. Nat. Immunol. 14, 372-379 (2013).
25. Hsu, H. C. et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. 9, 166-175 (2008).
26. Wu, H. J. et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815-827 (2010).
27. Scherer, H. U. et al. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis Rheum. 62, 1620-1629 (2010).
28. Rombouts, Y. et al. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann. Rheum. Dis. 74, 234-241 (2015).
29. Oefner, C. M. et al. Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs. The Journal of allergy and clinical immunology 129, 1647-1655 e1613 (2012).
30. Hess, C. et al. T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies. J. Clin. Invest. 123, 3788-3796 (2013).
31. Genovese, M. C. et al. Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study. Ann. Rheum. Dis. 72, 863-869 (2013).
32. Becker, C. et al. Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. J. Immunol. 177, 2760-2764 (2006).
33. Nandakumar, K. S. & Holmdahl, R. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis. J. Immunol. Methods 304, 126-136 (2005).
34. Ayoglu, B. et al. Autoantibody profiling in multiple sclerosis using arrays of human protein fragments. Mol. Cell. Proteomics 12, 2657-2672 (2013).
35. Lindh, I. et al. Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice. Arthritis Res. Ther. 16, R143 (2014).
36. Harre, U. et al. Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. Nat. Commun. 6, 6651 (2015).
37. Rombouts, Y. et al. Extensive glycosylation of ACPAs-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis. Ann. Rheum. Dis. 75, 578-585 (2015).
38. Selman, M. H. et al. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface. J. Proteomics 75, 1318-1329 (2012).
39. Zal, T., Volkmann, A. & Stockinger, B. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 180, 2089-2099 (1994).
40. Lutz, M. B. et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223, 77-92 (1999).
41. Krönke, G. et al. Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein. J. Biol. Chem. 278, 51006-51014 (2003).